These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7863828)

  • 41. Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin.
    Moonga BS; Alam AS; Bevis PJ; Avaldi F; Soncini R; Huang CL; Zaidi M
    J Endocrinol; 1992 Feb; 132(2):241-9. PubMed ID: 1541924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoblasts release osteoclasts from calcitonin-induced quiescence.
    Chambers TJ
    J Cell Sci; 1982 Oct; 57():247-60. PubMed ID: 6759515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uncoupling of receptor-mediated cellular responses by ionic lithium.
    Zaidi M; Patchell A; Datta HK; MacIntyre I
    J Endocrinol; 1989 Nov; 123(2):R5-7. PubMed ID: 2558141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the cytoskeleton of isolated chick osteoclasts: effect of calcitonin.
    Hunter SJ; Schraer H; Gay CV
    J Histochem Cytochem; 1989 Oct; 37(10):1529-37. PubMed ID: 2778308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of actin filaments, non-muscle myosin, M-Ras, and extracellular signal-regulated kinase (ERK) in osteoclasts after calcitonin administration.
    Nakamura H; Nagaoka N; Hirata A; Inoue M; Ozawa H; Yamamoto T
    Arch Histol Cytol; 2005 Jun; 68(2):143-50. PubMed ID: 16079460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcitonin effects on osteoclastic resorption: the 'escape phenomenon' revisited.
    Heersche JN
    Bone Miner; 1992 Mar; 16(3):174-7. PubMed ID: 1314121
    [No Abstract]   [Full Text] [Related]  

  • 47. Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.
    Azria M; Behhar C; Cooper S
    Calcif Tissue Int; 1993 Jan; 52(1):16-20. PubMed ID: 8240482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function.
    Zaidi M; Alam AS; Shankar VS; Bax BE; Moonga BS; Bevis PJ; Pazianas M; Huang CL
    Eur Biophys J; 1992; 21(5):349-55. PubMed ID: 1483410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biophysics and the nonlinear dynamics instigated by a special hormone.
    Javed S; Sohail A; Asif A; Nutini A
    Prog Biophys Mol Biol; 2020 Jan; 150():62-66. PubMed ID: 31121190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A quantitative study of the effects of prolonged calcitonin treatment on alveolar bone remodelling in the golden hamster.
    Baron R; Saffar JL
    Calcif Tissue Res; 1977 Feb; 22(3):265-74. PubMed ID: 843968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-1 alpha induces a sustained increase in cytosolic free calcium in cultured rabbit osteoclasts.
    Yu H; Ferrier J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):343-50. PubMed ID: 8384836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional consequences of the interaction of Ni2+ with the osteoclast Ca2+ 'receptor'.
    Bax BE; Shankar VS; Bax CM; Alam AS; Zara S; Moonga BS; Pazianas M; Huang CL; Zaidi M
    Exp Physiol; 1993 Jul; 78(4):517-29. PubMed ID: 8398105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Motility and resorption: osteoclastic activity in vitro.
    Ali NN; Boyde A; Jones SJ
    Anat Embryol (Berl); 1984; 170(1):51-6. PubMed ID: 6476408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibronectin induces pseudopod formation and cell migration by mobilizing internal Ca(2+) in blastoderm cells from medaka embryos.
    Shigemoto T
    Jpn J Physiol; 1999 Dec; 49(6):527-39. PubMed ID: 10603439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits.
    Reginster JY; Azria M; Gaspar S; Bleicher M; Franchimont N; Behhar M; Albert A; Franchimont P
    Calcif Tissue Int; 1992 Jun; 50(6):518-20. PubMed ID: 1525707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA synthesis in isolated rat osteoclasts: inhibitory effect of calcitonin.
    Zheng MH; Papadimitriou JM; Nicholson GC
    Bone; 1991; 12(5):317-22. PubMed ID: 1723609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of calcitonin, elevated calcium and extracellular matrices on superoxide anion production by rat osteoclasts.
    Datta HK; Manning P; Rathod H; McNeil CJ
    Exp Physiol; 1995 Sep; 80(5):713-9. PubMed ID: 8546861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcitonin and bone formation: a knockout full of surprises.
    Zaidi M; Moonga BS; Abe E
    J Clin Invest; 2002 Dec; 110(12):1769-71. PubMed ID: 12488426
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of a subtype of primary osteoclastoma: extracellular calcium but not calcitonin inhibits aggressive HLA-DR-positive osteoclastoma possessing 'functional' calcitonin receptors.
    Rathod H; Malcolm AJ; Gillespie JI; Berry V; Pooley J; Piggott NH; Datta HK
    J Pathol; 1994 Dec; 174(4):293-9. PubMed ID: 7884591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.